Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-07-04 @ 10:09 PM
Study NCT ID:
NCT04454658
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-16
First Post:
2020-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
Sponsor:
AbbVie
Organization: